CanadaBis Capital Inc (CANB) - Cash Flow Conversion Efficiency

Latest as of October 2025: 0.056x

Based on the latest financial reports, CanadaBis Capital Inc (CANB) has a cash flow conversion efficiency ratio of 0.056x as of October 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CA$437.61K ≈ $316.56K USD) by net assets (CA$7.80 Million ≈ $5.64 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See CanadaBis Capital Inc (CANB) net asset quality to measure how much of total assets are equity-financed.

CanadaBis Capital Inc - Cash Flow Conversion Efficiency Trend (2016–2025)

This chart illustrates how CanadaBis Capital Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check cash flow quality index of CanadaBis Capital Inc to evaluate the quality of earnings relative to operating cash generation.

CanadaBis Capital Inc Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of CanadaBis Capital Inc ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Montanaro UK Smaller Companies Investment Trust PLC LSE:MTU	-0.009x
Rubico Inc. Common Stock NASDAQ:RUBI	-0.056x
Tanah Laut Tbk JK:INDX	-0.023x
22nd Century Group Inc NASDAQ:XXII	0.174x
GEMINA LABS LTD F:8I7	-0.007x
Oakridge International Ltd AU:OAK	-0.447x
Flexituff Ventures International Limited NSE:FLEXITUFF	0.988x
Ngenic AB ST:NGENIC	0.592x

Annual Cash Flow Conversion Efficiency for CanadaBis Capital Inc (2016–2025)

The table below shows the annual cash flow conversion efficiency of CanadaBis Capital Inc from 2016 to 2025. For the full company profile with market capitalisation and key ratios, see CANB market cap overview.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-07-31	CA$7.92 Million ≈ $5.73 Million	CA$-3.20 Million ≈ $-2.31 Million	-0.403x	-1066.36%
2024-07-31	CA$7.41 Million ≈ $5.36 Million	CA$-256.31K ≈ $-185.41K	-0.035x	-104.58%
2023-07-31	CA$7.34 Million ≈ $5.31 Million	CA$5.55 Million ≈ $4.01 Million	0.755x	+2503.59%
2022-07-31	CA$2.63 Million ≈ $1.91 Million	CA$-82.77K ≈ $-59.88K	-0.031x	+96.83%
2021-07-31	CA$1.82 Million ≈ $1.32 Million	CA$-1.81 Million ≈ $-1.31 Million	-0.992x	+5.88%
2020-07-31	CA$3.43 Million ≈ $2.48 Million	CA$-3.62 Million ≈ $-2.62 Million	-1.054x	-77.49%
2019-07-31	CA$2.85 Million ≈ $2.06 Million	CA$-1.69 Million ≈ $-1.23 Million	-0.594x	-1993.66%
2018-07-31	CA$317.23K ≈ $229.48K	CA$9.95K ≈ $7.20K	0.031x	+120.18%
2017-07-31	CA$455.59K ≈ $329.57K	CA$-70.81K ≈ $-51.22K	-0.155x	--
2016-07-31	CA$150.00K ≈ $108.51K	CA$0.00 ≈ $0.00	0.000x	--

About CanadaBis Capital Inc

V:CANB Canada Drug Manufacturers - Specialty & Generic

Market Cap

$1.53 Million

CA$2.12 Million CAD

Market Cap Rank

#30234 Global

#1520 in Canada

Share Price

CA$0.02

Change (1 day)

+0.00%

52-Week Range

CA$0.01 - CA$0.05

All Time High

CA$0.55